DCAT 2010-2011 Board of Directors To Take Office November 1
Robbinsville, NJ, November 1, 2010 –
DCAT is pleased to announce that the slate of candidates for the 2010-2011 Board of Directors was approved by member company designated contacts. Bob Kanuga
, executive director external manufacturing operations at Merck & Co., Inc. will serve as president, taking office on November 1, along with the other elected board members.
Former DCAT President Joseph Principe
, vice president of global business development at Piramal Healthcare will join the Executive Committee’s Advisory Council.
, senior procurement manager, cGMP procurement at Genentech, Inc. joins the officers of the Executive Committee as vice president, and Ron Perry
, senior director, global leader, worldwide procurement at Pfizer, Inc. replaces her as vice president – pharmaceutical segment. Also joining the Executive Committee as vice president – biotechnology segment is Dave Cady
, director, global strategic sourcing at Amgen Inc. Pam Tyler
, purchasing manager at DPT Laboratories, Ltd. will join the Executive Committee in the newly created vice president- contract formulation, fill, finish and packaging position.
Completing their three-year-term on the Board of Directors are Mary Catherine Calisto,
business development manager at LANXESS Corp.; Folker Ruchatz,
director, pharma and human nutrition at BASF Orgamol Pharma Solutions S.A.; Helen Smyth Griffin,
purchasing manager at Novartis Pharmaceuticals Corp.; and Jeanne Thoma,
president, head of microbial control at Lonza Inc.
Completing his term on the DCAT Advisory Council is Joseph Colleluori
, head of corporate development at Lonza Inc. Colleluori served as the association's president in 2006-2007.
Also joining the Board are Eric Evans,
vice president & general manager, global API division, Covidien Mallinckrodt API Division; Ellen Gambichler,
director purchasing, E. Fougera & Co.; Michael Kopp,
vice president, N. American injectables, Mylan Pharmaceuticals, Inc.; Michael Rosenfelder,
director of business development, Merck & Co., Inc.; Joseph Sutton,
director, manufacturing procurement, Eli Lilly and Company; Ruben Valdez, Jr.,
global sourcing lead, Hospira; and Michael Velez,
sourcing director, Merck & Co., Inc.
Below is the full slate of newly elected Board of Directors:
Officers of the Executive Committee of the Board of Directors (1 Year Term):
Bob Kanuga, Executive Director, External Manufacturing Operations, Merck & Co., Inc.
Sr. Vice President:
Joan Connolly, Associate Vice President, Clinical Supplies and Logistics, ImClone Systems Inc.,
a wholly-owned subsidiary of Eli Lilly and Company
Tyson Popp, Vice President, Research & Development, West Pharmaceutical Services, Inc.
Lyra Myers, Senior Procurement Manager, cGMP Procurement, Genentech, Inc.
Vice Presidents of the Executive Committee of the Board of Directors (1 Year Term):
Biotechnology Industry Segment Vice President:
Dave Cady, Director, Global Strategic Sourcing, Amgen Inc.
Chemical Industry Segment Vice President
Donald LaFerle, President, Sales & Marketing, IRIX Pharmaceuticals, Inc.
Contract Formulation/Fill/Finish & Packaging Industry Segment Vice President:
Pam Tyler, Purchasing Manager, DPT Laboratories, Ltd.
Pharmaceutical Industry Segment Vice President
Ron Perry, Sr. Director, Worldwide Procurement, Pfizer Inc.
Pharmaceutical Services Industry Segment Vice President:
David McCleary, President, Custopharm, Inc.
Board of Directors (Term Ending Oct. 31, 2011):
Dennis Bauer, senior vice president, sales and marketing, Cherokee Pharmaceuticals, LLC
Thomas Miller, director, strategic sourcing, Bristol-Myers Squibb Worldwide Medicines Group
Rosina Vega, partner, GreenField Chemical, Inc.
Larry Walsh, business development manager--Health & Nutrition, Huber Engineered
Michiel Van Winden, business director, life science solutions, EMD Chemicals Inc.
Board of Directors (Term Ending Oct. 31, 2012):
Steve DeSalvo, director, contract manufacturing, USA, Fabbrica Italiana Sintetici S.p.A.
Eric Evans, vice president & general manger, global API division, Covidien Mallinckrodt
Sally Langa, vice president, business development, Patheon Inc.
Christopher Rayfield, vice president, sales & marketing, ACIC Fine Chemicals, Inc.
Malcolm Rosenthal, executive vice president, Austin Chemical Company, Inc.
Kevin Weithman, business development manager, The Dow Chemical Company
Board of Directors (Term ending Oct. 31, 2013):
Ellen Gambichler, Director of Purchasing, Nycomed US
Michael Kopp, Vice President, North American Injectables, Mylan Inc.
Michael Rosenfelder, Director of Business Development, Merck & Co., Inc.
Joseph Sutton, Director, Manufacturing Procurement, Eli Lilly and Company
Ruben Valdez, Global Sourcing Lead, Hospira, Inc.
Mike Velez, Sourcing Director, Merck & Co., Inc.
DCAT is the premier business development association whose membership is comprised of companies that manufacture, distribute or provide services to the pharmaceutical, chemical and related industries.
DCAT Communications Coordinator